Share
The Slate Daily feed includes new episodes from more than 30 shows in the Slate Podcast Network. You'll get thought provoking analysis, storytelling, and commentary on everything from news and politics to arts, culture, technology, and entertainment. Discover new shows you never knew you were missing.
…
continue reading
Manage episode 366782598 series 2861147
Content provided by Vinita Srivastava, The Conversation, Dannielle Piper, Krish Dineshkumar, Jennifer Moroz, Rehmatullah Sheikh, Kikachi Memeh, Ateqah Khaki, and Scott White. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinita Srivastava, The Conversation, Dannielle Piper, Krish Dineshkumar, Jennifer Moroz, Rehmatullah Sheikh, Kikachi Memeh, Ateqah Khaki, and Scott White or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
It seems like everyone you talk to has considered taking Ozempic, the drug originally created as a diabetes treatment, but now being used as a weight-loss method.
Ever since it arrived in Canada, it’s been in incredibly high demand.
While Ozempic may be just the next in a long line of get-thin-quick fads, the drug’s shortages have disproportionate impacts on racialized communities. So do the weight-loss goals that undergird those shortages.
88 episodes
))
